Medical Thrombus Aspiration Catheter

Medical Thrombus Aspiration Catheter Market Outlook

The global thrombus aspiration catheter market is anticipated to reach approximately USD 1.2 billion by 2035, with a compound annual growth rate (CAGR) of about 7.2% during the forecast period from 2025 to 2035. This growth can be attributed to the increasing prevalence of cardiovascular diseases and the growing number of interventional procedures aimed at treating these conditions. Additionally, advancements in catheter technology and the rising number of minimally invasive surgeries are expected to contribute significantly to market expansion. The aging population and the associated rise in chronic diseases further fuel the demand for efficient thrombus aspiration devices. Moreover, increasing healthcare expenditure and a growing number of specialized training programs for healthcare professionals are enhancing the adoption of these devices in clinical settings.

Growth Factor of the Market

The growth of the thrombus aspiration catheter market is driven by several key factors. First, the increasing incidence of cardiovascular diseases globally has led to a heightened need for effective treatment options, particularly through interventions that utilize thrombus aspiration catheters. As healthcare systems strive to improve patient outcomes, the adoption of advanced medical technologies that facilitate quicker recovery and reduced hospital stays has become paramount. Furthermore, the rise in awareness regarding the benefits of minimally invasive procedures has prompted many healthcare facilities to invest in thrombus aspiration technologies. Additionally, continuous research and development efforts aimed at enhancing the design and functionality of these catheters have resulted in innovative products that outperform traditional options. Regulatory support and favorable reimbursement policies are also playing a crucial role in encouraging adoption among healthcare providers.

Key Highlights of the Market

• Increasing prevalence of cardiovascular diseases driving demand for thrombus aspiration catheters.
• Technological advancements leading to enhanced catheter design and performance.
• Growing preference for minimally invasive surgical procedures among healthcare providers.
• Increased healthcare expenditure contributing to the adoption of advanced medical devices.
• Favorable reimbursement policies enhancing the accessibility of thrombus aspiration procedures.

By Product Type

Over-The-Wire Thrombus Aspiration Catheters:

Over-the-wire thrombus aspiration catheters are designed for use with a guide wire, allowing for precise placement and navigation within the vascular system. This type of catheter is particularly effective in retrieving thrombus from complex vascular lesions, making it a preferred choice in high-risk procedures. Due to their ability to provide better control during the aspiration process, these catheters are gaining traction among interventional cardiologists and vascular surgeons. The growing preference for over-the-wire systems is also supported by advancements in guide wire technology, which have optimized the performance of these catheters. As a result, over-the-wire thrombus aspiration catheters are expected to witness significant growth in market share during the forecast period.

Rapid Exchange Thrombus Aspiration Catheters:

Rapid exchange thrombus aspiration catheters allow for a quick and efficient procedure as they feature a simple exchange mechanism that enables easier access to the target site. This design minimizes the time required for catheter exchange and reduces the risk of complications associated with prolonged procedures. As healthcare providers increasingly prioritize speed and efficiency, rapid exchange catheters are becoming more popular in interventional procedures. Their ability to facilitate immediate thrombus removal in critical situations is a significant market driver. The growth in the adoption of these devices is further supported by positive clinical outcomes and improved patient safety profiles, establishing rapid exchange thrombus aspiration catheters as a vital component in modern interventional cardiology.

Balloon Aspiration Catheters:

Balloon aspiration catheters are equipped with an inflatable balloon that can occlude blood flow during the aspiration process, thereby enhancing thrombus retrieval efficiency. These devices are particularly beneficial in cases where blood flow dynamics can hinder successful aspiration. The ability to simultaneously inflate a balloon while aspirating provides a dual action that can lead to improved outcomes in challenging thrombus cases. As the field of interventional cardiology continues to evolve, the demand for balloon aspiration catheters is anticipated to grow, particularly in complex procedures requiring precise management of blood flow during thrombus extraction. This segment is expected to capture a significant share of the market due to its innovative mechanism and effectiveness.

Aspiration Pump Devices:

Aspiration pump devices are integral to the thrombus aspiration process, providing the necessary suction to facilitate effective thrombus removal. These devices enhance the overall efficacy of aspiration catheters by creating a controlled vacuum, which maximizes thrombus retrieval while minimizing the risk of embolization. The increasing integration of advanced technology into these devices, such as automated suction regulation and real-time monitoring, is driving their adoption across various clinical settings. As healthcare providers emphasize precision and safety in procedures, the demand for aspiration pump devices is expected to rise, bolstering the overall thrombus aspiration catheter market.

Others:

This category encompasses various unique and specialized thrombus aspiration catheters that may not fit into the standard classifications. Innovations in catheter design, such as those tailored for specific anatomical challenges or unique patient needs, are included in this segment. The diversity of products under the "others" category highlights the ongoing research and development efforts within the industry, as manufacturers strive to meet the evolving demands of healthcare providers and patients. Customization and adaptability are key trends driving growth in this segment, ensuring that a broad spectrum of clinical scenarios can be effectively addressed with advanced thrombus aspiration solutions.

By Application

Percutaneous Coronary Intervention:

Percutaneous coronary intervention (PCI) is one of the primary applications for thrombus aspiration catheters, as it plays a crucial role in treating coronary artery disease. In PCI, the use of thrombus aspiration catheters assists in the removal of thrombus that may obstruct blood flow during balloon angioplasty or stenting procedures. The increasing incidence of coronary artery disease globally is driving the demand for effective thrombus aspiration techniques within PCI. Clinicians recognize the benefits of these devices in improving procedural outcomes and reducing complications, which further enhances their adoption. As healthcare providers continue to seek innovative solutions for coronary interventions, the thrombus aspiration catheter segment specific to PCI is projected to witness robust growth.

Peripheral Vascular Intervention:

Thrombus aspiration catheters are increasingly utilized in peripheral vascular interventions, where they serve to clear occlusions in peripheral arteries and veins. With the growing prevalence of peripheral artery disease (PAD) and the associated complications, there is a rising demand for effective treatment options that can restore blood flow. The efficacy of thrombus aspiration catheters in improving outcomes for patients undergoing peripheral vascular procedures is well-recognized. As interventionalists aim for faster recovery times and improved patient safety, the adoption of thrombus aspiration techniques in peripheral vascular intervention is expected to grow significantly. This application segment is a key focus area within the overall thrombus aspiration catheter market, driven by an expanding patient population.

Neurovascular Intervention:

In the realm of neurovascular intervention, thrombus aspiration catheters play a vital role in managing acute ischemic stroke and other neurovascular disorders. The ability to rapidly remove thrombus from cerebral vessels can dramatically affect patient outcomes, emphasizing the importance of these devices in emergency care settings. As the incidence of stroke continues to rise globally, healthcare providers are increasingly relying on thrombus aspiration technologies to facilitate timely interventions. Advanced thrombus aspiration catheters designed for neurovascular use are being developed, which are tailored to meet the unique anatomical challenges of the neurovascular system. This segment is poised for growth as awareness and treatment capabilities in neurovascular interventions continue to advance.

Others:

The "others" category for applications includes various unique procedures beyond the traditional uses of thrombus aspiration catheters. This may involve innovative uses in specialized surgeries or emerging applications in other fields of medicine, such as oncology or emergency trauma care. As research in interventional techniques progresses, the potential for thrombus aspiration catheters to be applied in new contexts is expanding. The adaptability of these devices allows them to be utilized in diverse clinical scenarios, driving interest and investment in this application segment. As new techniques are developed and regulatory approvals granted, the market for thrombus aspiration catheters in non-traditional applications is expected to grow.

By Distribution Channel

Hospitals:

Hospitals remain the primary distribution channel for thrombus aspiration catheters, accounting for a significant portion of the market. These facilities are equipped with advanced interventional suites and have the necessary infrastructure to perform complex procedures requiring thrombus removal. The availability of skilled healthcare professionals and specialized training within the hospital environment fosters the use of thrombus aspiration technologies. Additionally, hospitals often invest in cutting-edge medical devices, ensuring that they have access to the latest innovations in catheter technology. The increasing number of interventional procedures performed in hospitals due to the rising prevalence of cardiovascular diseases is further propelling growth in this distribution channel.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are emerging as a significant distribution channel for thrombus aspiration catheters, particularly as the trend towards outpatient procedures becomes more prevalent. ASCs provide a cost-effective and efficient alternative to traditional hospital settings for various interventional procedures, including those involving thrombus aspiration. The ability to perform many procedures in a minimally invasive manner allows patients to recover faster and return home the same day, enhancing patient satisfaction. As healthcare systems seek to reduce costs and improve patient throughput, the growth of ASCs in the thrombus aspiration catheter market is anticipated to continue, driven by the advantages they offer.

Specialty Clinics:

Specialty clinics, particularly those focusing on cardiology and vascular surgery, represent an important distribution channel for thrombus aspiration catheters. These clinics often have a patient base specifically seeking advanced interventional treatments, making them key players in the distribution landscape. The emphasis on specialized care in these settings allows for tailored treatment options and enhanced patient outcomes. As the demand for personalized and high-quality healthcare increases, specialty clinics are likely to expand their offerings of thrombus aspiration technologies. This growth is supported by an increasing number of partnerships with medical device manufacturers to ensure access to the latest products in the market.

Others:

The "others" category for distribution channels encompasses various unconventional settings where thrombus aspiration catheters may be utilized. This can include research institutions, emergency medical services, and telemedicine platforms that offer specialized care. Innovations in telemedicine are creating opportunities for remote consultations and treatment planning, particularly for patients who may be unable to access traditional medical facilities. As research and education continue to evolve, the use of thrombus aspiration catheters in these unique distribution channels is expected to gain traction, contributing to the overall market growth.

By Material Type

Nitinol:

Nitinol, a nickel-titanium alloy known for its unique properties of flexibility and shape memory, is increasingly being used in the manufacturing of thrombus aspiration catheters. The material's ability to revert to its original shape after deformation provides significant advantages in terms of navigation through complex vascular pathways. Nitinol's biocompatibility and resistance to fatigue make it an ideal choice for interventional devices. As healthcare providers seek advanced materials that enhance performance and reduce procedural risks, the demand for nitinol-based thrombus aspiration catheters is on the rise, reflecting a broader trend towards the use of innovative materials in medical devices.

Stainless Steel:

Stainless steel has long been a trusted material in the medical device industry, and it remains a common choice for thrombus aspiration catheters due to its strength and durability. Stainless steel catheters offer excellent structural integrity, making them suitable for high-pressure applications. Additionally, the ease of sterilization and ability to resist corrosion further enhance their appeal in clinical settings. The combination of these properties ensures that stainless steel catheters can withstand the rigors of interventional procedures while maintaining safety and efficacy. As the market evolves, stainless steel is expected to continue to play an important role in the thrombus aspiration catheter segment.

Polyurethane:

Polyurethane is gaining traction as a preferred material for thrombus aspiration catheters, particularly due to its flexibility and biocompatibility. The material's inherent properties allow for the creation of catheters that can easily navigate through curved blood vessels while minimizing trauma to surrounding tissues. The use of polyurethane in catheter design also enables better control during aspiration procedures, enhancing overall performance. As the demand for safe and effective medical devices grows, the adoption of polyurethane-based thrombus aspiration catheters is expected to increase, driven by their ability to meet the needs of both healthcare providers and patients.

Others:

This category includes a variety of alternative materials used in thrombus aspiration catheter production, reflecting the ongoing innovation within the industry. New materials are being researched and developed to enhance catheter performance, reduce complications, and improve patient outcomes. These innovations may encompass composite materials or novel polymers that offer unique properties, such as enhanced compliance or reduced friction during insertion. The emphasis on material science in catheter development is indicative of the broader trends towards customization and specialization in medical devices. As research continues, "others" in material types may become an increasingly influential segment in the thrombus aspiration catheter market.

By Region

The thrombus aspiration catheter market is geographically segmented into several regions, each contributing distinctively to the overall growth. North America dominates the market, accounting for approximately 40% of the global share, driven by advanced healthcare infrastructure and high patient awareness regarding cardiovascular diseases. The increasing number of interventional procedures, combined with favorable reimbursement policies, has further solidified North America's position as a leader in the thrombus aspiration catheter market. The region is expected to grow at a CAGR of around 7.5% during the forecast period, reflecting ongoing investments in healthcare technology and innovation.

In Europe, the thrombus aspiration catheter market is experiencing significant growth, with a share of about 30%. The rise in chronic diseases, coupled with an aging population, is driving demand for effective thrombus management solutions across various healthcare settings. Additionally, the increasing emphasis on minimally invasive surgical techniques aligns with the growing adoption of thrombus aspiration devices in this region. The Asia Pacific region is also witnessing rapid growth, with a market share of around 20%. The expanding healthcare sector in countries like China and India, along with rising awareness of cardiovascular health, is contributing to the overall market expansion. As healthcare infrastructure continues to improve, the Asia Pacific region is projected to experience the highest growth rate in the thrombus aspiration catheter market.

Opportunities

The thrombus aspiration catheter market presents numerous opportunities for growth and innovation, particularly in the area of technological advancements. Companies that invest in research and development to create next-generation products that enhance efficacy and safety will likely capture significant market share. There is an increasing focus on developing catheters that are compatible with various imaging techniques, allowing for real-time visualization during procedures. Such advancements not only improve procedural outcomes but also enhance the overall experience for both patients and healthcare providers. As medical technology continues to evolve, incorporating smart design and advanced materials into thrombus aspiration catheters can create lucrative opportunities for manufacturers.

Moreover, the rising awareness of cardiovascular health and the increasing prevalence of related diseases are creating a growing demand for thrombus aspiration catheters. Public health initiatives aimed at educating the population about the risks of cardiovascular diseases and the importance of early intervention are likely to spur demand for these devices. Additionally, as healthcare systems globally continue to prioritize minimally invasive techniques, the adoption of thrombus aspiration devices will likely increase. This trend opens doors for market players to explore partnerships, collaborations, and mergers to expand their reach and enhance product offerings, ultimately catering to the evolving needs of healthcare providers and patients.

Threats

Despite the promising growth prospects for the thrombus aspiration catheter market, there are several threats that manufacturers and stakeholders must navigate. One significant threat is the intense competition among market players, which can lead to price wars and reduced profit margins. As more companies enter the market, the need for differentiation through innovation becomes critical. Additionally, the rapid pace of technological advancements requires companies to continually invest in research and development to stay relevant. Failure to keep up with industry trends and consumer demands can result in market share loss and diminished brand reputation.

Another challenge includes regulatory hurdles that manufacturers must overcome to ensure their products meet safety and efficacy standards. The process of obtaining regulatory approvals can be lengthy and resource-intensive, which may deter new entrants and slow down product launches. Furthermore, stringent regulations may lead to increased compliance costs, impacting overall market profitability. Lastly, fluctuating economic conditions and healthcare spending can pose risks to market growth, as budget constraints may limit the availability and accessibility of advanced medical devices, potentially hindering the adoption of thrombus aspiration catheters.

Competitor Outlook

• Boston Scientific Corporation
• Medtronic plc
• Abbott Laboratories
• Terumo Corporation
• Asahi Intecc Co., Ltd.
• Cook Medical LLC
• Cardinal Health, Inc.
• Penumbra, Inc.
• AngioDynamics, Inc.
• Edwards Lifesciences Corporation
• Teleflex Incorporated
• Conmed Corporation
• BD (Becton, Dickinson and Company)
• MediGlobe AG
• Microvention, Inc.

The competitive landscape of the thrombus aspiration catheter market is characterized by the presence of several prominent players, each striving for innovation and market leadership. Major companies are focusing on product development and technological advancements to enhance the efficacy and safety of their thrombus aspiration products. Collaborations and partnerships are prominent strategies employed by these companies to leverage each other's strengths, ultimately improving their market position. In addition, companies are investing significantly in research and development activities to introduce novel products tailored to meet the specific needs of interventional cardiologists and vascular surgeons.

Boston Scientific Corporation and Medtronic plc are among the leading players in the thrombus aspiration catheter market, both known for their extensive portfolios and commitment to innovation. Boston Scientific has made significant strides in developing advanced catheter technologies that improve patient outcomes, while Medtronic's offerings emphasize a broad range of interventional solutions. Abbott Laboratories is also a key player, offering products that address the needs of healthcare providers in various clinical settings. These companies hold significant market shares, benefiting from their strong brand recognition and established distribution networks.

Emerging companies such as Penumbra, Inc., and Microvention, Inc. are also making notable contributions to the market by focusing on niche applications and innovative designs tailored for specific medical challenges. Their commitment to research and development has led to the introduction of advanced thrombus aspiration technologies that cater to the evolving demands of healthcare providers. As the market continues to expand, these companies are positioned to capitalize on growth opportunities by addressing unmet needs within the thrombus aspiration catheter segment.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 MediGlobe AG
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Medtronic plc
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Penumbra, Inc.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Cook Medical LLC
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Conmed Corporation
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Microvention, Inc.
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Terumo Corporation
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Abbott Laboratories
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 AngioDynamics, Inc.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Cardinal Health, Inc.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Teleflex Incorporated
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Asahi Intecc Co., Ltd.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Boston Scientific Corporation
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Edwards Lifesciences Corporation
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 BD (Becton, Dickinson and Company)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Medical Thrombus Aspiration Catheter Market, By Application
    • 6.1.1 Percutaneous Coronary Intervention
    • 6.1.2 Peripheral Vascular Intervention
    • 6.1.3 Neurovascular Intervention
    • 6.1.4 Others
  • 6.2 Medical Thrombus Aspiration Catheter Market, By Product Type
    • 6.2.1 Over-The-Wire Thrombus Aspiration Catheters
    • 6.2.2 Rapid Exchange Thrombus Aspiration Catheters
    • 6.2.3 Balloon Aspiration Catheters
    • 6.2.4 Aspiration Pump Devices
    • 6.2.5 Others
  • 6.3 Medical Thrombus Aspiration Catheter Market, By Material Type
    • 6.3.1 Nitinol
    • 6.3.2 Stainless Steel
    • 6.3.3 Polyurethane
    • 6.3.4 Others
  • 6.4 Medical Thrombus Aspiration Catheter Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Ambulatory Surgical Centers
    • 6.4.3 Specialty Clinics
    • 6.4.4 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Medical Thrombus Aspiration Catheter Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Medical Thrombus Aspiration Catheter market is categorized based on

By Product Type

• Over-The-Wire Thrombus Aspiration Catheters
• Rapid Exchange Thrombus Aspiration Catheters
• Balloon Aspiration Catheters
• Aspiration Pump Devices
• Others

By Application

• Percutaneous Coronary Intervention
• Peripheral Vascular Intervention
• Neurovascular Intervention
• Others

By Distribution Channel

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Others

By Material Type

• Nitinol
• Stainless Steel
• Polyurethane
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Boston Scientific Corporation
• Medtronic plc
• Abbott Laboratories
• Terumo Corporation
• Asahi Intecc Co., Ltd.
• Cook Medical LLC
• Cardinal Health, Inc.
• Penumbra, Inc.
• AngioDynamics, Inc.
• Edwards Lifesciences Corporation
• Teleflex Incorporated
• Conmed Corporation
• BD (Becton, Dickinson and Company)
• MediGlobe AG
• Microvention, Inc.